181 related articles for article (PubMed ID: 31087723)
1. Pharmacogenetic role of dopamine transporter (SLC6A3) variation on response to disulfiram treatment for cocaine addiction.
Kampangkaew JP; Spellicy CJ; Nielsen EM; Harding MJ; Ye A; Hamon SC; Kosten TR; Nielsen DA
Am J Addict; 2019 Jul; 28(4):311-317. PubMed ID: 31087723
[TBL] [Abstract][Full Text] [Related]
2. ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse.
Spellicy CJ; Kosten TR; Hamon SC; Harding MJ; Nielsen DA
Pharmacogenet Genomics; 2013 Jul; 23(7):333-40. PubMed ID: 23635803
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase.
Kosten TR; Wu G; Huang W; Harding MJ; Hamon SC; Lappalainen J; Nielsen DA
Biol Psychiatry; 2013 Feb; 73(3):219-24. PubMed ID: 22906516
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic randomized trial for cocaine abuse: disulfiram and α1A-adrenoceptor gene variation.
Shorter D; Nielsen DA; Huang W; Harding MJ; Hamon SC; Kosten TR
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1401-7. PubMed ID: 23849431
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.
Haile CN; Kosten TR; Kosten TA
Am J Drug Alcohol Abuse; 2009; 35(3):161-77. PubMed ID: 19462300
[TBL] [Abstract][Full Text] [Related]
6. Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment.
Schottenfeld RS; Chawarski MC; Cubells JF; George TP; Lappalainen J; Kosten TR
Drug Alcohol Depend; 2014 Mar; 136():36-42. PubMed ID: 24462581
[TBL] [Abstract][Full Text] [Related]
7. Modifying the role of serotonergic 5-HTTLPR and TPH2 variants on disulfiram treatment of cocaine addiction: a preliminary study.
Nielsen DA; Harding MJ; Hamon SC; Huang W; Kosten TR
Genes Brain Behav; 2012 Nov; 11(8):1001-8. PubMed ID: 22925276
[TBL] [Abstract][Full Text] [Related]
8. The OPRD1 rs678849 variant influences outcome of disulfiram treatment for cocaine dependency in methadone-maintained patients.
Thomas PS; Nielsen EM; Spellicy CJ; Harding MJ; Ye A; Patriquin M; Hamon SC; Kosten TR; Nielsen DA
Psychiatr Genet; 2021 Jun; 31(3):88-94. PubMed ID: 33953123
[TBL] [Abstract][Full Text] [Related]
9. A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample.
Guindalini C; Howard M; Haddley K; Laranjeira R; Collier D; Ammar N; Craig I; O'Gara C; Bubb VJ; Greenwood T; Kelsoe J; Asherson P; Murray RM; Castelo A; Quinn JP; Vallada H; Breen G
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4552-7. PubMed ID: 16537431
[TBL] [Abstract][Full Text] [Related]
10. Crack cocaine users show differences in genotype frequencies of the 3' UTR variable number of tandem repeats of the dopamine transporter gene (DAT1/SLC6A3).
Stolf AR; Szobot CM; Halpern R; Akutagava-Martins GC; Müller D; Guimaraes LS; Kessler FH; Pechansky F; Roman T
Neuropsychobiology; 2014; 70(1):44-51. PubMed ID: 25247548
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders.
Brewer AJ; Nielsen DA; Spellicy CJ; Hamon SC; Gingrich J; Thompson-Lake DG; Nielsen EM; Mahoney JJ; Kosten TR; Newton TF; De La Garza R
Pharmacogenet Genomics; 2015 Jun; 25(6):296-304. PubMed ID: 25850966
[TBL] [Abstract][Full Text] [Related]
12. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans.
Martinez D; Gelernter J; Abi-Dargham A; van Dyck CH; Kegeles L; Innis RB; Laruelle M
Neuropsychopharmacology; 2001 May; 24(5):553-60. PubMed ID: 11282255
[TBL] [Abstract][Full Text] [Related]
13. Association of Dopamine Transporter Gene with Heroin Dependence in an Indian Subpopulation from Manipur.
Koijam AS; Hijam AC; Singh AS; Jaiswal P; Mukhopadhyay K; Rajamma U; Haobam R
J Mol Neurosci; 2021 Jan; 71(1):122-136. PubMed ID: 32557146
[TBL] [Abstract][Full Text] [Related]
14. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.
Bonvicini C; Faraone SV; Scassellati C
Mol Psychiatry; 2016 Jul; 21(7):872-84. PubMed ID: 27217152
[TBL] [Abstract][Full Text] [Related]
15. Characterization of VNTRs Within the Entire Region of SLC6A3 and Its Association with Hypertension.
Kim WT; Lee SR; Roh YG; Kim SI; Choi YH; Mun MH; Jeong MS; Koh SS; Leem SH
DNA Cell Biol; 2017 Mar; 36(3):227-236. PubMed ID: 28055236
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients.
Oliveto A; Poling J; Mancino MJ; Feldman Z; Cubells JF; Pruzinsky R; Gonsai K; Cargile C; Sofuoglu M; Chopra MP; Gonzalez-Haddad G; Carroll KM; Kosten TR
Drug Alcohol Depend; 2011 Jan; 113(2-3):184-91. PubMed ID: 20828943
[TBL] [Abstract][Full Text] [Related]
17. Association between the Intron 8 VNTR Polymorphism of the DAT1 Gene and Crack Cocaine Addiction.
Stolf AR; Müller D; Schuch JB; Akutagava-Martins GC; Guimaraes LSP; Szobot CM; Halpern R; Kessler FHP; Pechansky F; Roman T
Neuropsychobiology; 2017; 75(3):141-144. PubMed ID: 29332099
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of DAT1 and COMT differentially associate with actigraphy-derived sleep-wake cycles in young adults.
Valomon A; Holst SC; Bachmann V; Viola AU; Schmidt C; Zürcher J; Berger W; Cajochen C; Landolt HP
Chronobiol Int; 2014 Jun; 31(5):705-14. PubMed ID: 24625311
[TBL] [Abstract][Full Text] [Related]
19. Ventral midbrain correlation between genetic variation and expression of the dopamine transporter gene in cocaine-abusing versus non-abusing subjects.
Zhou Y; Michelhaugh SK; Schmidt CJ; Liu JS; Bannon MJ; Lin Z
Addict Biol; 2014 Jan; 19(1):122-31. PubMed ID: 22026501
[TBL] [Abstract][Full Text] [Related]
20. Association between the 9 repeat allele of the dopamine transporter 40bp variable tandem repeat polymorphism and Alzheimer's disease.
Fehér Á; Juhász A; Pákáski M; Kálmán J; Janka Z
Psychiatry Res; 2014 Dec; 220(1-2):730-1. PubMed ID: 25130782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
